BCR and B-cell non-Hodgkin lymphoma: At the same time, the profound increase in basal activation may actually contribute to impaired PI3K signaling upon BCR stimulation in these cells, as aberrant basal signaling associated with reduced activation-induced signaling has been observed in B-cell lymphoma and malignancies [49].